Jane Street’s Astria Therapeutics ATXS Stock Holding History

Jane Street’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,000	Closed	-$137K	–	9545
2024 Q2	$137K	Sell	15,000 -87,900	-85%	-$858K	﹤0.01%	8620
2024 Q1	$1.45M	Buy	+102,900	New	+$1.28M	﹤0.01%	4720

Jane Street's ATXS Position: Q1 2026 in Review

Jane Street sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 173,511 shares — an estimated $2.27M sold.

Jane Street first reported a position in ATXS in Q3 2017 and held it in 19 quarters. The position peaked at $2.27M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Jane Street reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Jane Street sold 173,511 Astria Therapeutics shares in Q1 2026, an estimated $2.27M.
Jane Street first reported a position in Astria Therapeutics in Q3 2017 and held it in 19 quarters.
Jane Street's Astria Therapeutics position peaked at $2.27M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.